| Pharmaceuticals | Specialized medicines across multiple therapeutic areas including internal medicine, oncology, hospital care, vaccines, immunology. | Strong R&D, established brand equity, extensive distribution networks, and strategic alliances. | B2B and B2C, including hospitals, healthcare providers, and direct patient sales. | Novel therapies in immunology and oncology, vaccine products, and specialty hospital medicines. | 2128 | 100 | Revenue from sales of prescription medicines, vaccines, and hospital products. | Primarily direct sales with negotiated pricing for hospital tenders and institutional clients. | Innovation pipeline, new product launches, expanded healthcare access, and strategic partnerships. | Corex, Becosules, Dolonex, Minipress XL, Eliquis, Enbrel, Prevenar 13, Neksium, Betrecep, Zavicefta |
